LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp., (NASDAQ: SNTA) a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is appointing Michael P. Bailey Senior Vice President and Chief Commercial Officer. Mr. Bailey will join Synta August 4th, 2008.
